D
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A136.0 KBDecibel Therapeutics, Inc.Feb 14, 4:55 PM ET·0001104659-24-023911
- SC 13D/A58.4 KBDecibel Therapeutics, Inc.Sep 27, 4:05 PM ET·0001104659-23-104277
- 8-K432.6 KBDecibel Therapeutics, Inc.Sep 25, 8:56 AM ET·0001193125-23-240971
- 8-K147.4 KBDecibel Therapeutics, Inc.Aug 25, 7:04 AM ET·0001193125-23-220651
- SC 13D314.1 KBDecibel Therapeutics, Inc.Aug 18, 5:16 PM ET·0001104659-23-093555
- 10-Q10.2 MBDecibel Therapeutics, Inc.Aug 11, 7:30 AM ET·0000950170-23-041603
- 8-K1.1 MBDecibel Therapeutics, Inc.Aug 9, 8:02 AM ET·0001193125-23-206819
- 8-K206.2 KBDecibel Therapeutics, Inc.Jun 13, 4:30 PM ET·0000950170-23-027704
- 10-Q9.5 MBDecibel Therapeutics, Inc.May 15, 7:30 AM ET·0000950170-23-021967
- 8-K528.0 KBDecibel Therapeutics, Inc.Apr 6, 4:01 PM ET·0000950170-23-012063
Insiders
10Tickers
No tickers on record
Addresses
business
1325 BOYLSTON STREET SUITE 500
BOSTON, MA, 02215
mailing
1325 BOYLSTON STREET SUITE 500
BOSTON, MA, 02215